Entries by Wally Graham

Alloy inks $4M farm-in deal with Doray

THE BOURSE WHISPERER: Investors with an eye for the gold sector have been wondering for some time what the next move may be of gold miner Doray Minerals (ASX: DRM) after successfully bringing its Andy Well gold mine on stream. Those questions have been answered with the announcement that Doray has entered into a farm-in […]

This Week in The Roadhouse Pharmacy

THE ROADHOUSE PHARMACY: There’s a great deal of interest in the Bio-tech sector at the moment, so we have opened our own Pharmacy to keep our readers up to speed. Clinuvel Pharmaceuticals scores US orphan-drug designation Clinuvel Pharmaceuticals (ASX: CUV) has announced that afamelanotide, the active ingredient in the company’s proprietary drug SCENESSE®, has received […]

What the Brokers Say

WHAT THE BROKERS SAY: Interesting news and views from across the Resource Analyst universe. Website: www.hartleys.com.au Buxton Resources Limited (ASX: BUX) Magmatic nickel-copper sulphide intersected at Zanthus Buxton Resources recently completed RC drilling at the Zanthus project in the Fraser Range, confirming the presence of highly prospective mafic/ultramafic rocks and more importantly identified magmatic nickel-copper […]

Funds across the Boards

THE FUND RAISER: Some bigger numbers this week as the juniors boosted their bank balances. Capital Raising Sovereign Metals (ASX: SVM) will place up to 15.25 million ordinary shares at 22 cents each to sophisticated investors, to raise $3.35 million before costs. Aterra Capital, a key investor and substantial holder in the company with 10.5 […]

Clinuvel Pharmaceuticals scores US orphan-drug designation

THE ROADHOUSE PHARMACY: Clinuvel Pharmaceuticals (ASX: CUV) has announced that afamelanotide, the active ingredient in the company’s proprietary drug SCENESSE®, has received orphan-drug designation from the US Food and Drug Administration (FDA) for the rare Hailey-Hailey Disease (HHD, also known as familial benign chronic pemphigus). Clinuvel exlpained that orphan-drug designation is granted by the FDA’s […]

Hi Ho, Hi Ho, it’s off to work we go

THE DRILL SERGEANT: Each week any number of junior exploration plays set out to drill their ground. Here’s a small selection of what’s been happening this week. Drilling commences on high-priority targets White Cliff Minerals (ASX: WCN) has commenced a 1000 to 2000 metre RC drilling program testing four nickel sulphide targets at the company’s […]

Plymouth Minerals receives first Morille drill results

THE DRILL SERGEANT: Plymouth Minerals (ASX: PLH) has taken receipt of the assay results from its first phase of drilling to be completed at the company’s Morille tungsten-tin project in Spain. The company said it had completed a total of 3,982 metres, which was extended from an initially planned 3,500 metres in 61 Reverse Circulation […]

Upcoming Floats

THE BOURSE WHISPERER: A quick look at some up and coming Resource companies waiting to list on the boards of the ASX. American Patriot Oil & Gas Limited Proposed ASX code: AOW Proposed listing date: 12 may 2014 American Patriot is an oil and natural gas exploration and development (E&P) group, focused on oil and […]

Argonaut increases stake in Lumwana West project

THE BOURSE WHISPERER: Argonaut Resources (ASX: ARE) has upped its ante in Zambia via its wholly-owned subsidiary, Lumwana West Resources, which has increased its shareholding in Mwombezhi Resources from 51 per cent to 90 per cent. Mwombezhi Resources holds a 100 per cent interest in the Lumwana West copper project in Zambia. Argonaut increased its […]